Related Experiment Video
Updated: May 11, 2026
23:33
The WATCHMAN Left Atrial Appendage Closure Device for Atrial Fibrillation
Published on: February 28, 2012
[Pharmacological rate control therapy for atrial fibrillation]
1Department of Cardiology, Yokohama City University Hospital.
Summary
For atrial fibrillation patients, lenient heart rate control is as effective as strict control for survival. This approach is simpler to achieve and recommended, especially for those with heart failure.
Area of Science:
- Cardiology
- Pharmacology
Context:
- Atrial fibrillation (AF) management often involves balancing rhythm and rate control strategies.
- Anticoagulation is crucial for AF patients to prevent stroke.
- Heart failure (HF) complicates AF management, requiring careful consideration of treatment effects.
Purpose:
- To evaluate the comparative effectiveness of lenient versus strict rate control in patients with atrial fibrillation.
- To assess the impact of rate control strategies on survival rates, particularly in patients with concomitant heart failure.
- To review the pharmacological options for rate control in atrial fibrillation.
Summary:
- Studies indicate no significant survival difference between rhythm and rate control in anticoagulated AF patients, including those with heart failure.
- Lenient rate control (resting heart rate <110 bpm) is as effective as strict rate control (resting heart rate <70 bpm) in permanent AF and easier to achieve.
- Pharmacological options include digitalis, beta-blockers, and calcium channel blockers, each with specific effects on heart rate and contractility, with beta-blockers showing promise in heart failure.
Impact:
- Findings suggest a less stringent approach to rate control in AF may be sufficient, simplifying treatment regimens.
- Beta-blockers emerge as a potentially beneficial option for rate control in AF patients with heart failure, improving cardiac function and survival.
- This evidence supports optimizing AF management by prioritizing patient safety and treatment feasibility.
Related Concept Videos
01:25Dysrhythmias VI: Management of Dysrhythmias
Dysrhythmia management involves a multifaceted approach, incorporating pharmacological treatments, medical procedures, surgical interventions, lifestyle modifications, and patient education.Pharmacological ManagementAntiarrhythmic Drugs:Class I (Sodium Channel Blockers): This class includes quinidine and procainamide, which reduce the speed of impulse conduction in the heart, stabilize the cardiac membrane, and control arrhythmias. Quinidine and procainamide are Class IA agents that prolong the...
01:20Antiarrhythmic Drugs: Class IV Agents as Calcium Channel Blockers
Class IV antiarrhythmic drugs, such as verapamil and diltiazem, block calcium channels. They primarily affect the heart, slowing the conduction in calcium-dependent tissues like the SA and AV nodes. These drugs manage reentrant supraventricular tachycardia (SVT) and reduce ventricular rate in atrial flutter/fibrillation.
Verapamil, a calcium channel blocker, inhibits calcium movement across myocardial cell membranes and vascular smooth muscle. This results in the dilation of coronary and...
Verapamil, a calcium channel blocker, inhibits calcium movement across myocardial cell membranes and vascular smooth muscle. This results in the dilation of coronary and...
01:24Antiarrhythmic Drugs: Class II Agents as β-Adrenergic Blockers
Adrenergic stimulation generally impacts cardiac rate and rhythm. Specifically, stimulation of the β-adrenoceptors triggers an increase in intracellular calcium ion influx and pacemaker currents, which may cause arrhythmias. Catecholamines like adrenaline also demonstrate β2-adrenoceptor-mediated hypokalemia, impacting cardiac action potential and disrupting the normal cardiac rhythm. Class II antiarrhythmic drugs are β-adrenoceptor antagonists or β-blockers, which indirectly block calcium...
01:12Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers
Class III antiarrhythmic drugs are a group of medications that can prolong action potentials in the heart. They achieve this by blocking potassium channels or enhancing inward currents from sodium channels. However, these drugs have a unique property of "reverse use-dependence," which is most pronounced at slower heart rates and can lead to torsades de pointes—a specific type of arrhythmia. However, it is essential to note that excessive QT interval prolongation—a measure of the heart's...
01:25ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias
Arrhythmia is a condition characterized by an irregular heart rhythm, with ECG changes that differ based on its origin and nature. The types of arrhythmias discussed below include atrial, junctional, and ventricular arrhythmias.Atrial ArrhythmiasPremature Atrial Complexes (PACs): PACs are early atrial beats caused by stress, caffeine, alcohol, electrolyte imbalances, hypoxia, hyperthyroidism, or certain medications (e.g., bronchodilators and decongestants). The ECG shows early P waves with an...
01:29Disturbances in Heart Rhythm
Arrhythmia or dysrhythmia refers to an abnormal heart rhythm caused by a defect in the heart's conduction system. It can cause the heart to beat irregularly, too quickly, or too slowly, leading to symptoms like chest pain, shortness of breath, and fainting. Factors such as stress, caffeine, alcohol, nicotine, cocaine, certain drugs, congenital defects, diseases, and electrolyte abnormalities can trigger arrhythmias.
Arrhythmias are categorized by their speed, rhythm, and origin. A slow heart...
Arrhythmias are categorized by their speed, rhythm, and origin. A slow heart...